文献速递牙体牙髓病

阿替卡因与利多卡因在下颌第一、第二磨牙不可逆牙髓炎补充浸润麻醉中的疗效比较:前瞻性随机双盲临床试验

Efficacy of Articaine versus Lidocaine in Supplemental Infiltration for Mandibular First versus Second Molars with Irreversible Pulpitis: A Prospective, Randomized, Double-blind Clinical Trial.
PubMed 文献 · J Endod · 2018-02-01

结果显示IANB成功率为25%;第一磨牙中两种药物补充BI成功率相似,第二磨牙中阿替卡因成功率显著高于利多卡因。

要点

  • 4%阿替卡因IANB在不可逆牙髓炎下颌磨牙中成功率仅25%。
  • 第一磨牙补充BI:阿替卡因61%与利多卡因66%成功率无显著差异。

核心结论

  • 4%阿替卡因IANB成功率为25%,补充BI中阿替卡因与利多卡因在第一磨牙疗效相似,但在第二磨牙阿替卡因显著更成功。

主要发现

  • 4%阿替卡因IANB成功率为25%。

关键数值与推荐

  • 成功定义为根管进入和器械操作时Heft-Parker视觉模拟量表疼痛程度低于轻度。
  • 补充BI在浸润后5分钟开始根管进入。

临床怎么用

  • 下颌第二磨牙不可逆牙髓炎IANB失败后,补充BI优先选择4%阿替卡因。
  • 第一磨牙补充BI可选用阿替卡因或利多卡因,两者成功率相似。
  • 因补充BI常不能达到深度牙髓麻醉,必要时需采用骨内麻醉等额外技术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Profound pulpal anesthesia is difficult to achieve in mandibular molars with irreversible pulpitis (IP). However, there are no published randomized controlled clinical trials comparing the success of supplemental buccal infiltration (BI) in mandibular first versus second molars with IP. The purpose of this prospective, randomized, double-blind study was to compare the efficacy of 4% articaine with 2% lidocaine for supplemental BIs in mandibular first versus second molars with IP after a failed inferior alveolar nerve block (IANB). This study's sample was combined with data from a previous trial. METHODS: One hundred ninety-nine emergency subjects diagnosed with IP of a mandibular molar were selected and received an IANB with 4% articaine. Subjects who failed to achieve profound pulpal anesthesia, determined by a positive response to cold or pain upon access, randomly received 4% articaine or 2% lidocaine as a supplemental BI. Endodontic access was begun 5 minutes after infiltration. Success was defined as less than mild pain during endodontic access and instrumentation on the Heft-Parker visual analog scale. RESULTS: There was a 25% IANB success rate with 4% articaine. The success rate for articaine supplemental BI in first molars was 61% versus 63% for second molars (P > .05). The success of lidocaine in first molars was 66%, but for second molars it was 32% (P = .004). CONCLUSIONS: The success rate for IANB with 4% articaine was 25%. Articaine and lidocaine had similar success rates for supplemental infiltration in first molars, whereas articaine was significantly more successful for second molars. However, because BI often did not provide profound pulpal anesthesia, additional techniques including intraosseous anesthesia may still be required.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Shapiro MR, McDonald NJ, Gardner RJ, et al. Efficacy of Articaine versus Lidocaine in Supplemental Infiltration for Mandibular First versus Second Molars with Irreversible Pulpitis: A Prospective, Randomized, Double-blind Clinical Trial. J Endod. 2018. PMID: 29397214. doi:10.1016/j.joen.2017.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。